Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€472.90
08.07.21
-
08.07.22
-21.99%
08.07.22

Saftman 
08.07.21 50%
buy
Stratec SE

Start price
Target price
Perf. (%)
€117.40
08.07.21
-
08.07.22
-19.51%
08.07.22

Prof 
08.07.21 50%
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.90
02.07.21
-
02.07.22
-20.90%
09.03.22

Innovative
Dependend from some customers or products
Higher risks for its business
ElectricPlayer 
02.07.21 50%
buy
Paul Hartmann AG

Start price
Target price
Perf. (%)
€353.00
30.06.21
€400.00
30.06.22
3.40%
10.07.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Covacoro 
30.06.21 70%
buy
Bayer AG

Start price
Target price
Perf. (%)
€51.63
28.06.21
€58.00
18.01.23
10.09%
18.01.23

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
Snowman 
28.06.21 60%
buy
Evotec SE

Start price
Target price
Perf. (%)
€37.08
21.06.21
-
21.06.22
4.91%
29.06.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Fair valuation
High Investments for future growth
Mori8 
21.06.21 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.02
21.06.21
-
21.06.22
-2.25%
06.07.21

Mori8 
21.06.21 50%
buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€413.70
18.06.21
€600.00
18.06.22
35.75%
27.09.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
High valuation
tbackenh 
18.06.21 95%
buy
co.don AG

Start price
Target price
Perf. (%)
€1.41
17.06.21
-
17.06.23
-13.17%
17.06.23

Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
17.06.21 0%
buy
Bayer AG

Start price
Target price
Perf. (%)
€52.22
03.06.21
-
03.06.22
-2.82%
26.02.22

Revenue growth > 30% per year expected
Undervalued
High Investments for future growth
Top Rating
Maleri 
03.06.21 50%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.30
02.06.21
-
02.06.22
9.09%
20.06.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
02.06.21 0%
buy
M1 Kliniken AG

Start price
Target price
Perf. (%)
€10.35
31.05.21
-
31.05.24
40.10%
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
31.05.21 50%
buy
Haemato AG

Start price
Target price
Perf. (%)
€29.20
31.05.21
-
31.05.24
-36.99%
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
31.05.21 50%
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€75.60
26.05.21
€82.00
26.05.22
-36.11%
27.05.22

matumba 
26.05.21 80%
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.10
19.05.21
€80.00
19.11.21
-1.41%
26.05.21

Revenue growth > 30% per year expected
Undervalued
High Investments for future growth
Top Rating
Maleri 
19.05.21 100%
buy
MPH Health Care AG

Start price
Target price
Perf. (%)
€26.00
16.05.21
€40.00
16.05.22
-5.77%
29.01.22

Could be very worthwhile Investment >20% year
Undervalued
Future proof or reliable business model
Significant cyclical dependencies
jomobb 
16.05.21 90%
sell
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€74.55
07.05.21
€60.00
07.05.22
-37.42%
08.05.22

Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
Snowman 
07.05.21 50%
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€40.55
04.05.21
€55.00
04.05.22
-11.84%
05.05.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Undervalued
Kirus 
04.05.21 50%
sell
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€81.20
03.05.21
€75.00
03.05.22
-41.82%
04.05.22

Could be worthwhile Investment >10% per year
melinda 
03.05.21 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€53.83
03.05.21
€65.00
03.05.22
13.13%
04.05.22

Differentiated customer and product portfolio
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
skatcup 
03.05.21 80%
buy
Haemato AG

Start price
Target price
Perf. (%)
€28.90
02.05.21
€35.00
02.05.22
-4.50%
15.05.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Covacoro 
02.05.21 0%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.70
02.05.21
-
02.05.22
1.08%
16.05.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
02.05.21 0%
buy
Formycon AG

Start price
Target price
Perf. (%)
€66.90
18.04.21
-
18.04.22
-16.59%
21.12.21

Could be worthwhile Investment >10% per year
Savour 
18.04.21 30%
sell
Sartorius AG VZO

Start price
Target price
Perf. (%)
€468.70
16.04.21
€440.00
16.04.22
-18.50%
17.04.22

Probably not worthwhile Investment
Very low/no dividend yield expected
Snowman 
16.04.21 50%
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€73.50
15.04.21
€88.00
15.04.22
10.48%
03.05.21

Could be worthwhile Investment >10% per year
melinda 
15.04.21 20%